GL1X · GenesisL1 explorer

MolNFT v1 · #90178 · protein

Blac E166A faropenem acyl-intermediate complex

4EBL · Beta-lactamase: “Blac E166A faropenem acyl-intermediate complex”. X-ray diffraction, 2 ligands (DGF, PO4), 7 pockets (best druggability 0.71). MolNFT v1 #90178 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4EBL
Type
protein
Length
1,060 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
P0C5C1
Ligands
DGF, PO4
Pockets
7 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, DBeta-lactamase (EC 3.5.2.6)protein26546% helix, 17% strandP0C5C1

Ligands and binding sites

  • DGF · (2R,5R)-2-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-5-[(2R)-tetrahydrofuran-2-yl]-2,5-dihydro-1,3-thiazole-4-carboxylic acid · ligand · 2 copies · chains B, C
  • PO4 · Phosphate ion · ion · 8 copies · chains A, B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17440.710.7779DGF
25850.690.7854DGF
31000.620.8926PO4
4920.580.8729PO4
52360.510.7646empty

Interfaces

4 interfaces between chains.

  • C–D · 835 Ų buried · 9 hydrogen bonds · protein-protein
  • A–B · 824 Ų buried · 7 hydrogen bonds · protein-protein
  • B–D · 658 Ų buried · 2 hydrogen bonds · protein-protein
  • A–C · 649 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 4EBL · BlaC E166A Faropenem Acyl-Intermediate Complex · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.